Scholarlink

<p>Traumatic brain injury (TBI) is a complex and often-devastating condition. This disease involves damage to cerebral structures: meninges (dura, arachnoid, pia), cerebral cortex, white matter tracts, and deeper structures (basal ganglia, brainstem), along with mechanisms including contusions, hematomas (epidural/subdural), diffuse axonal injury from shear forces, secondary edema compromising blood-brain barrier, and ischemia/hemorrhage caused by vascular disruption. The pathophysiological process of TBI above varies significantly among individuals. However, prevalent TBI treatments still focus on symptomatic management, such as surgical intervention represented by craniotomy, medical management represented by osmotic agents for cerebral edema, supportive care represented by oxygen therapy, and adjuvant therapies represented by hypothermia. Worse still, traditional therapies often yield unfavorable outcomes and indulge the potential onset of long-term neurodegenerative diseases (NDDs). On the other side, Glymphatic System (GS), discovered as a clearance system in the brain, has made tremendous progress over the past decade. Dysfunction of the GS has been implicated in various central nervous system (CNS) diseases including TBI. The discovery of the GS offers new perspectives for the pathophysiological process of TBI, particularly unveiling the truth of the development of diphasic brain edema following TBI. Impressively, with the GS maturing, unprecedented therapeutic strategies ensue. For instance, the GS might explain sleep deprivation after TBI strikes in part and strongly validate the prospect of sleep therapy, then provide insights into the enigma of sleep. Also, nor-adrenergic inhibition facilitates CSF-ISF exchange and glymphatic outflow, significantly attenuating brain edema. AQP4, the guardian and regulator of brain capacity at the end-foot of astrocyte, which can modulate its array and amounts aligning with nor-adrenergic signal, is indispensable in this process. Moreover, neurons have gained prominence in the brain’s clearance system. Exploring the relationship between the GS and TBI will likely to blaze the new trail for advancing our understanding of TBI.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Perceiving traumatic brain injury from glymphatic system

  • 期刊论文

  • 发表日期：

    2025年7月31日

查看全文
  • Zeyi Yang,
  • Pengtao Li,
  • Junji Wei

摘要

Traumatic brain injury (TBI) is a complex and often-devastating condition. This disease involves damage to cerebral structures: meninges (dura, arachnoid, pia), cerebral cortex, white matter tracts, and deeper structures (basal ganglia, brainstem), along with mechanisms including contusions, hematomas (epidural/subdural), diffuse axonal injury from shear forces, secondary edema compromising blood-brain barrier, and ischemia/hemorrhage caused by vascular disruption. The pathophysiological process of TBI above varies significantly among individuals. However, prevalent TBI treatments still focus on symptomatic management, such as surgical intervention represented by craniotomy, medical management represented by osmotic agents for cerebral edema, supportive care represented by oxygen therapy, and adjuvant therapies represented by hypothermia. Worse still, traditional therapies often yield unfavorable outcomes and indulge the potential onset of long-term neurodegenerative diseases (NDDs). On the other side, Glymphatic System (GS), discovered as a clearance system in the brain, has made tremendous progress over the past decade. Dysfunction of the GS has been implicated in various central nervous system (CNS) diseases including TBI. The discovery of the GS offers new perspectives for the pathophysiological process of TBI, particularly unveiling the truth of the development of diphasic brain edema following TBI. Impressively, with the GS maturing, unprecedented therapeutic strategies ensue. For instance, the GS might explain sleep deprivation after TBI strikes in part and strongly validate the prospect of sleep therapy, then provide insights into the enigma of sleep. Also, nor-adrenergic inhibition facilitates CSF-ISF exchange and glymphatic outflow, significantly attenuating brain edema. AQP4, the guardian and regulator of brain capacity at the end-foot of astrocyte, which can modulate its array and amounts aligning with nor-adrenergic signal, is indispensable in this process. Moreover, neurons have gained prominence in the brain’s clearance system. Exploring the relationship between the GS and TBI will likely to blaze the new trail for advancing our understanding of TBI.